Objective: The aim of the study was to examine whether neural state of spared motor and premotor cortices captured before a therapy predicts therapy-related motor gains in chronic subcortical stroke. Design: Ten survivors, presenting chronic moderate upper limb impairment, underwent proton magnetic resonance spectroscopy, magnetic resonance imaging, clinical, and kinematics assessments before a 4-wk impairment-oriented training. Clinical/kinematics assessments were repeated after therapy, and motor gain was defined as positive values of clinical upper limb/elbow motion changes and negative values of trunk motion changes. Candidate predictors were N-acetylaspartate-neuronal marker, glutamate-glutamine-indicator of glutamatergic neurotransmission, and myo-inositol-glial marker, measured bilaterally within the upper limb territory in motor and premotor (premotor cortex, supplementary motor area) cortices. Traditional predictors (age, stroke length, pre-therapy upper limb clinical impairment, infarct volume) were also investigated. Results: Poor motor gain was associated with lower glutamate-glutamine levels in ipsilesional primary motor cortex and premotor cortex (r = 0.77, P = 0.01 and r = 0.78, P = 0.008, respectively), lower N-acetylaspartate in ipsilesional premotor cortex (r = 0.69, P = 0.02), higher glutamate-glutamine in contralesional primary motor cortex (r = −0.68, P = 0.03), and lower glutamate-glutamine in contralesional supplementary motor area (r = 0.64, P = 0.04). These predictors outperformed myo-inositol metrics and traditional predictors (P ≈ 0.05-1.0). Conclusions: Glutamatergic state of bilateral motor and premotor cortices and neuronal state of ipsilesional premotor cortex may be important for predicting motor outcome in the context of a restorative therapy.
D
espite remarkable advances in the field of stroke for the past several decades, commonly available rehabilitation therapies for upper limb motor function are characterized by only modest efficacy (only 11.6% of the patients demonstrating complete functional recovery at 6-mo poststroke). 1 Thus, the restoration of upper limb function continues to be an unfulfilled goal for over 7 million persons with stroke in the United States. 2 As stroke mortality decreases in parallel with advances in acute stroke care, it is expected that more patients with upper limb impairment will survive for the next decades. Such impairment poses barriers to independence and community integration and diminishes quality of life. 3 Given these facts, evidence-based improvements in stroke rehabilitation are of high priority.
More accurate models for predicting the patient's capacity for upper limb recovery would be helpful in developing and validating novel, effective restorative therapies. Such models would also enable clinicians to optimize rehabilitation, improve stroke care quality, better allocate the rehabilitation resources, and help patients manage expectations. The current study has been focusing on the chronic phase of stroke (defined here as greater than 6 mo after stroke) in which the extent of brain injury and the alternative cortical networks recruited in both injured (ipsilesional) and uninjured (contralesional) hemispheres to assist the paretic upper limb movement become established. 4 In this phase of stroke, numerous predictors (i.e., demographic, 5 genetic variation, 6 baseline clinical status, 5 neuropsychological status, 7 metrics of brain injury, 7, 8 functional integrity of motor and premotor cortices or cortical resources 7, 8 ) have been tried. Unfortunately, these predictors, either in isolation or in combination, have not provided useful models for healthcare management or rehabilitation service allocation. 9 A possible explanation for this shortfall is the preferential enrollment of patients with good baseline clinical status, leaving little opportunity for measurable improvement and limiting generalizability. Indeed, to estimate the cortical resources, the patients should have the ability to engage in a behavioral paradigm (task-related functional magnetic resonance imaging [MRI] studies), endure extended testing (resting-state functional MRI), or exhibit motor-evoked potentials in affected muscle (transcranial magnetic stimulation). Thus, the cortical resources have not been broadly explored in patients with severe upper limb paresis and/or limited capacity to extended testing. Proton magnetic resonance spectroscopy ( 1 H-MRS) is a safe, non-invasive tool that could be administrated in these patients. Notably, this tool is uniquely able to measure neural state, by means of biomarkers related to neuronal and glial integrity, inflammation/necrosis, intracortical excitability/inhibition, and intracellular metabolism in discrete regions of the human brain. 10 Our previous stroke 1 H-MRS studies provide evidences of functionally relevant abnormalities in biomarkers specific to neuronal and glial integrity across ipsilesional motor and premotor cortices. 11, 12 Of direct relevance to the current study, these data demonstrate that 1 H-MRS provides probes of stroke-related remote cortical changes that span on microscopic cellular level of analysis. Thus, 1 H-MRS measures may add, without question, new insights into the pathophysiology of motor recovery after stroke.
The aim of the current study was to investigate for the first time whether pre-therapy neural state of the motor (M1) and premotor (premotor cortex [PM] , supplementary motor area [SMA] ) cortices are predictive of therapy-related motor gain in a subcortical ischemic stroke sample evincing severe to mild upper limb impairment. Based on the aforementioned neural alterations reported in these areas 11 and the findings from functional MRI/transcranial magnetic stimulation studies suggesting that functional activation and excitability are critical to recovery potential and improvements with restorative therapies, 7, 8 the first hypothesis was that altered neuronal-glial interactions and lower intracortical excitability (as evidenced by lower levels of a neuronal biomarker, N-acteylaspartate [NAA], higher levels of a glial biomarker, myo-inositol [mIn] , and lower levels of a glutamatergic neurotransmission biomarker, glutamateglutamine complex [Glx] respectively) within the ipsilesional cortices would be associated with poor motor gain. A different pattern would be expected for the contralesional cortices; because there are no significant neuronal-glial alterations in these areas in chronic stroke, 11 no correlations would be expected between the levels of neuronal/glial biomarkers and motor gain; based on maladaptive relevance of hyperexcitability in the contralesional hemisphere, 13 an inverse relationship would be expected between the levels of glutamatergic neurotransmission biomarker and motor gain. In addition to the primary hypothesis, we also examined several traditional predictors of motor recovery after stroke, such as patient's age, time post-injury, infarct volume, and pre-therapy upper limb clinical impairment.
MATERIALS AND METHODS

Stroke Survivors' Enrolment
Written informed consent in accordance with the institutional review board, University of Kansas Medical Center, was obtained from all participants before enrollment.
Note that the stroke survivors studied here were part of a large group who participated in earlier overarching study describing remote neurochemical changes arising from stroke and their functional relevance. The cross-sectional component of this study revealed, as stated previously, significant alterations of neuronal-glial interactions in ipsilesional M1, which were related to the proximal and distal clinical motor impairment of the upper limb 11 and to the activation pattern of the same area, as measured by functional MRI.
12 Similar neuronal-glial alterations were reported in the ipsilesional premotor areas, and these alterations were specifically related to the proximal upper limb motor impairment. 11 Ten patients completed the longitudinal (interventional) component of this study and were studied as follows. They were selected if they have had a single symptomatic subcortical ischemic stroke without cortical involvement (confirmed on T2-weigthed images-see hereinafter) occurring at least 6 mo before study enrollment, presented upper limb motor deficits (upper limb Fugl-Meyer test, 14 FM <66), and had adequate comprehension (able to follow simple 3-step commands, e.g., point to the ceiling, floor, and face in this order). Patients were also required to have no visual attention deficits (cancellation test), apraxia (clinical observation of the use of scissors to cut paper and making coffee), other neurological or psychiatric diseases, substance/alcohol abuse or dependence, or MRI contraindications. There were no gender or handedness exclusions.
To evaluate the pre-stroke 1 H-MRS and kinematics (see hereinafter) metrics, we also included 16 age/sex/academic performance-matched healthy controls with normal T2-weighted images and with no history of neurological, psychiatric, or orthopedic disease, head trauma, substance abuse, or MRI contraindications.
Study Protocol
Pre-therapy assessment of 1 H-MRS metrics was obtained within 24-hrs before therapy-a 4-wk impairment-oriented motor training. Candidate predictors included biomarkers of neuronal-glial interactions and glutamatergic state. Traditional stroke predictors included brain injury metrics (infarct volume) and pre-therapy demographics/clinical status (age, time post-stroke, upper limb impairment). Upper limb clinical impairment was again evaluated within 24 hrs after motor training. To identify the therapy-related changes in movement pattern, we also investigated kinematics of upper limb and trunk before and after therapy. Motor gain (or motor recovery) was defined as positive values of changes in clinical scores and upper limb kinematics (reflective of improved upper limb motor control) and negative values of changes in trunk kinematics (decreased behavioral compensation). 15, 16 Pre-therapy Brain Injury Assessment Magnetic Resonance Imaging Acquisition
Magnetic resonance imaging studies were performed on a Siemens 3T Allegra MR system. The details of MR scans have been described previously. 11 Specifically, two structural data sets were acquired: 
Magnetic Resonance Imaging Analysis
The brain injury metrics extracted were the infarct volume and the white matter changes (hyperintensities, WMH).
A stroke mask was created on each patient's MRI by manually tracing each lesion on slice-by-slice basis in the axial view of T1-weigthed images in MedINRIA software (Medical Image Navigation and Research Toll by INRIA, Cedex, France). Lesion was defined as tissue with abnormal high signal intensity on each image (Fig. 1A) and as subcortical if they are situated for 50% or more at the subcortical level. 17 Infarct volume was calculated using MIPAV (http://mipav.cit.nih. gov/). Intra-rater reliability was verified by repeated drawing (two times) of three lesions by one investigator (SCC) and the inter-rater reliability by comparing the drawings of two investigators (CMC and SCC) of the three lesions.
White matter hyperintensity was assessed on T2-weighted and was rated according to the Fazekas visual rating scale. 18 Shortly, this is a scale grading WMH according to severity (0 = none or a single punctate lesion, 1 = multiple punctate lesions, 2 = early confluency of lesions, and 3 = large confluent lesions). The scores 0 and 1 are considered normal in the elderly.
Pre-therapy Motor and Premotor Cortices Neurochemistry Assessment
H-MRS Acquisition
Immediately after the structural MRI acquisition was completed, H-MRSI was performed with point-resolved spectroscopy sequence with water suppression (PRESS, TR = 1500 ms, TE = 30 ms, FOV = 160 mm, matrix size = 16 Â 16, thickness = 15 mm). Scalp lipid artifact was minimized with eight outer voxel suppression bands. Shimming was performed using field-map based automatic shimming routines followed by manual adjustments, resulting in full width at half maximum of water signals of less than 20 Hz. 11 Importantly, this approach did not require the patient's engagement in any behavioral paradigm or the presence of motor evoked potentials in affected muscles and took approximately 15 mins.
H-MRS Analysis
Analysis methods for 1 H-MRS data have been detailed previously. 11 Briefly, LCModel 19 was used to quantify concentrations of the following three neurochemicals most likely associated with neural plasticity 10 : NAA, mIn, and Glx, considered here as candidate predictors. The hand/upper limb territory was identified in each ROI based on the following anatomical landmarks: the omega shape or hand knob on the anterior bank of the central sulcus for M1, the anterior half of precentral gyrus adjacent to the hand knob for PM, and about 1 cm rostral to the paracentral sulcus for SMA (http:// neuro.imm.dtu.dk/services/jerne/ninf/voi.html).
Neurochemicals' concentrations were corrected for partial brain tissue volume within each spectroscopic voxel using inhouse software written in Matlab (2013a Mathworks, Natick, MA). Brain tissue volume was calculated using T1-weighted images segmented to grey matter, white matter, and cerebrospinal fluid (SPM8, Wellcome Trust Center for Neuroimaging, University College London, London, United Kingdom). Neurochemicals with Cramér-Rao lower bounds values less than 15% and voxels with a signal-to-noise ratio greater than 10 were included in the analysis (Fig. 1B) . The corrected concentration was then converted into molar concentrations (millimoles per kilogram wet weight brain tissue). 11 Approximately three spectroscopic voxels were selected in each ROI, and mean (SD) values were obtained for each neurochemical per ROI.
Therapy
Impairment-Oriented Motor Training
This motor training was built on our and other previous studies. 15, 20 Specifically, stroke survivors underwent 12 practice sessions (90 repetitions/day, 3 days/wk, a total of 1080 repetitions) for 4 consecutive wks. Therapy consisted of repeated reach-to-grasp task with the paretic upper limb. This task was selected because it is familiar to participants, has a great chance of generalization, and is of high ecological relevance. Further, this task should be reacquired during recovery from stroke. From the motor control perspective, this task involves the hand control and coordinated motions between the shoulder and elbow joints to reach the target with a very limited trunk recruitment. 15 However, after stroke, the contribution of the trunk could be considerable in accomplishment of this action 15 (see hereinafter).
Participant was seated at approximately 15 cm distance in front of a table ( Fig. 2A) . At the initial position, the participant rested the paretic upper limb on the table. A cylindrical object was placed within a comfortable range for grasping (about 90% arm's length, vertically oriented) on a platform located in front of the patient. Nine cylindrical objects of varying diameters (4, 6, and 8 cm diameter-similar diameters to those of routinely used objects, i.e., can, cup, and jar) and weights (50, 100, and 150 g) were used. Objects were presented in a random order. The variable practice was chosen on the basis of the large advantages of this type of practice relative to constant practice on performance and retention. 21 In response to an auditory signal, the participant reached and grasped the object with the whole hand and transported it to the initial position at a comfortable self-selected speed. The patient had no upper limb or trunk restrictions during movement. Visual feedback about elbow extension motion was provided by an electrogoniometer (Exos, Inc, Woburn, MA) placed on the lateral epicondyle and displayed on a computer screen at the end of the task. The mean elbow extension from the healthy control group was presented as a target goal on the same screen. To minimize dependence on feedback, the feedback frequency was decreased throughout the practice session (for the first 30 trials, feedback was provided every trial, for the second 30 trials, every second trial, and for the last 30 trials, every fifth trial). All participants completed the training sessions.
Pre-therapy and Post-therapy Clinical Evaluation
A single clinical assessor rated each patient using the FM, with higher scores reflecting greater function (total score, normal = 66). In addition to the FM total score, we also selected FM components specifically dealing with proximal movements, including active shoulder and elbow movements in and out of synergy (proximal subscore, normal = 30), and distal movements, including hand and wrist movements (distal subscore, normal = 24).
Pre-therapy and Post-therapy Movement Kinematics Assessment
The clinical test used here (FM) is mainly focus on task accomplishment and is not qualitatively sensitive enough to discriminate how the task is achieved (see review by Lemmens et al. 22 ). Kinematic analysis may overcome this limitation. 23 As stated previously, by using this analysis, we strived to FIGURE 2. A, Impairment-oriented training consisted of repeated reach-to-grasp task with the paretic upper limb (1080 repetitions for 4 wks) focusing the participant's attention on a specific component of motor impairment, i.e., decreased elbow extension. Seated participant had the paretic arm rested on the table placed in front of the body. The contralateral arm rested alongside the body. The seat height was adjusted according to the participant's lower leg length, so the feet could rest comfortably on the floor and the table height was set to coincide with the mid-point between the inferior margin of the sternum and the umbilicus. The participant reached and grasped an object, placed on a platform located in front and at shoulder height and on median line, with the whole hand and transported it to the initial position at a comfortable self-selected speed. The participant had no arm or trunk restrictions during movement. Visual feedback about their elbow extension (reported to a "healthy" movement for patients) was provided with faded frequency throughout the practice session. B, Individual proximal and distal FM subscores before (black symbols) and after (white symbols) therapy in stroke survivors. Healthy values for FM proximal is 30 and for distal is 24. differentiate between true motor recovery-restitution of the original upper limb function and behavioral compensation-a mechanism to facilitate upper limb function by compensating for the distal upper limb weakness. 15, 16 The latter has been widely studied by Cirstea and Levin 15, 16 and mainly includes the use of new degrees of freedom, i.e., trunk, during motor tasks executed with the paretic upper limb. For example, during reaching, the patients increased the trunk forward displacement to compensate for lack of or diminished active range of elbow extension to bring the hand to the target. 16 Here, we assessed the upper limb and trunk kinematics using a reach-to-grasp task, a similar task to the trained task.
The workstation included a 4-cm-diameter cylinder placed on a platform located in front of the participant. This cylinder was aligned with the midline of the trunk and located at 90% of extended arm's length and at the participant's shoulder height. At the initial position, the participant had the arm to be trained rested on the table located ipsilaterally (elbow angle = 90 degrees, measured by means of goniometer). The contralateral arm rested alongside the body. We instructed participants to reach and grasp the cylinder in response to an auditory tone and hold the hand in the final position, until a second tone signaled the end of the trial. There were no restrictions of trunk or upper limb movements or feedback provided during data recording.
Before recording, participants practiced the task five times. Then, 20 movements performed with full vision were recorded by using motion analysis system (VICON; Oxford Metrics). Five reflective balls were positioned on the participant's upper limb (#1-ulnar process; #2-lateral epicondyle; acromion processes of #3-ipsilateral and #4-contralateral shoulder) and sternum (#5). Each movement was recorded for 3 to 6 secs at a sampling rate of 100 Hz. The vectors joining the reflective balls #1, #2, and #3 were used to compute the elbow motion, and the displacement in the sagittal plane of the #5 was used to define trunk motion. Specifically, the elbow extension (degrees, deg) and anterior trunk displacement (centimeter, cm) were calculated as the differences between the final and the initial positions of the corresponding vectors.
Statistical Analysis
The participant characteristics were summarized by frequencies and proportions for qualitative covariates (stroke side, medication) and by means and SD for 1 H-MRS predictors (levels of NAA, mIn, and Glx in each ROI), traditional predictors (age, time post-stroke, log-transformed infarct volume), clinical (FM), and kinematics (elbow and trunk motions) metrics.
The distribution of normality for predictors and clinic/ kinematics metrics was evaluated using Shapiro-Wilk test. All, but three (log-transformed infarct volume, P = 0.03; time after stroke, P = 0.001; trunk motion, P = 0.01), were normally distributed. t test (or the Wilcoxon rank sum test if the data were not normally distributed) was employed to assess the reliability of infarct volume and WMH measurements and the changes in the clinical/kinematic metrics from pre-therapy to post-therapy. Analysis of variance was performed to assess between-group differences in each 1 H-MRS biomarker after adjusting for hemisphere.
Spearman rank order correlation test was employed to determine the relationships between predictors ( 1 H-MRS and traditional) and therapy-related changes in clinical/kinematics metrics (ΔFM = FM post − FM pre , Δelbow, Δtrunk). Significant level was considered at P value of less than 0.05 (SPSS 23.0; SPSS Inc, Chicago, IL). Table 1) . Eight of 10 patients (80%) presented with right hemiparesis. All were premorbid right handed. Patients were not apraxic, cognitively impaired, or clinically depressed, and they were not receiving current inpatient/outpatient treatment or spasticity medication. Patients were on antihypertensive (90%), cholesterol-lowering (50%), and/or antiplatelet (90%) therapy.
RESULTS
Participant Characteristics
Control group provided an adequate comparison group with no differences in potential confounding demographic influences: age (58.7 [6.8] 14 three had mild upper limb weakness (gross and fine movements with subtle deficits, FM from 57 to 64), six moderate (gross and some fine movements, 23 to 50), and one patient had severe weakness (gross motor function only, 10) ( Table 1) .
Although all participants completed the reach component of the task (with or without compensatory trunk use), the severely to moderately impaired patients did not have sufficient motor control to perform the whole action-some grasped the objects from the top, where some were not able to transport the objects to the initial position. Thus, the kinematic metrics presented and discussed here are primarily related to the reach component of the task. As expected, 23 
Pre-therapy MRI Findings
Review of T1-and T2-weigthed images showed that participants had sustained a single cerebral infarction. No participants had lesions involving the M1, PM, or SMA. The infarct volume varied from 0.5 to 25.3 cm 3 with an average of 8.1 (10.1) cm 3 . Both intra-rater and inter-rater reproducibility of infarct volume measurements were high (Wilcoxon rank sum test, P < 0.001 and P < 0.01, respectively). Fazekas scores varied between 0 and 1, reflective of no lesion or punctate lesions, which are considered normal in the elderly persons. Similarly, a high agreement regarding WMH was found between the two evaluators (paired t test, P < 0.001 for both intra-rater and interrater analyses).
Pre-therapy 1 H-MRS Findings
Brain tissue volumes were similar between stroke and control groups ( Table 2 ), suggesting that neurochemicals presented here have been corrected for a similar brain tissue volume regardless the group. As we previously shown, 11 the stroke survivors displayed significantly altered neuronal-glial interactions ipsilesionally (lower levels of NAA in both M1 and SMA, higher levels of mIn in PM), no contralesional neuronal-glial alterations, and no glutamatergic alterations in either ipsilesional or contralesional hemisphere (Table 2) .
Therapy Gain
Stroke survivors showed significant clinical gain after 4 wks of training (FM total, t = −5.1 P = 0.000). Similar to findings reported from studies involving a similar training protocol, 15 the magnitude of ΔFM ranged from 1 to 9 points with an overall mean (SD) increase of 3.9 (2.4) points. A higher number of patients improved the proximal FM subscores (70%) compared with those who improved the distal subscores (40%, Fig. 2B ). This could be explained, at least partially, by the feedback provided during the training. However, considering the lack of consensus on the best measurements of improvement to be used as definitive outcomes in stroke research and the fact that FM subscores have not been validated before, we used FM total for the analyses hereinafter.
Patients also improved the active range of elbow extension (from 35. The correlation coefficients between the 1 H-MRS biomarkers, traditional predictors, and motor gain (ΔFM total, Δelbow, Δtrunk) are presented in Table 3 .
Depressed Excitability in Ipsilesional M1 Was Associated to Poor Motor Gain
As predicted, the levels of Glx in M1 were positively correlated with both ΔFM total (r = 0.77, P = 0.01) and Δelbow (r = 0.77, P = 0.01) ( Table 3 and Fig. 3A left and central panels). This finding is consistent with the view that the level of the ipsilesional M1 excitability may be related to upper limb motor recovery. 7, 8, 24 Importantly, these relationships persisted after controlling for age (r = −0.79, P = 0.007 and r = 0.86, P = 0.001, respectively) or time post-stroke (r = 0.79, 0.006 and r = 0.80, P = 0.005).
Depressed Excitability and Neuronal Metabolism in Ipsilesional PM Were Associated With Poor Motor Gain
Again, as expected, the levels of Glx and NAA in PM were positively correlated with ΔFM total (r = 0.78, P = 0.008 and r = 0.69, P = 0.002, respectively) ( Table 3 and Fig. 3A right  panel) . These data provide further support for the potential role of the ipsilesional PM in upper limb motor recovery in the context of a restorative therapy (see review by Plow et al. 25 ). Notably, age and time post-stroke have no substantial effect on these relationships (age, r = 0.62, P = 0.05 and r = 0.76, P = 0.01, respectively; time post-stroke, r = 0.71, P = 0.02 and r = 0.82, P = 0.003).
Hyperexcitability in Contralesional M1 Was Associated With Poor Motor Gain
Consistent with the maladaptive relevance of the contralesional M1 changes in excitability, 13 the levels of Glx in M1 were negatively related to Δtrunk (r = −0.68, P = 0.03) ( Table 3 and Fig. 3B left panel) . This suggests that patients with hyperexcitable contralesional M1 increased the use of the compensatory strategies available rather than improving their paretic upper limb. This relationship persisted after controlling for age (r = −0.62, P = 0.05) or time after stroke (r = −0.65, P = 0.04).
Depressed Excitability in Contralesional SMA Was Associated With Poor Motor Gain
Contrary to our expectations, the levels of Glx in contralesional SMA were positively associated with ΔFM (r = 0.64, P = 0.04) ( Table 3 and Fig. 3B right panel) . This finding broadly agrees with the quite selective nature for the contralesional brain regions engaged in stroke recovery. Age had no substantial effect on this relationship (r = 0.62, P = 0.05) but time after stroke had (r = 0.47, P = 0.2).
Others 1 H-MRS Biomarkers and Traditional Predictors did not Predict Therapy Gain
N-acteylaspartate levels in ipsilesional M1, ipsilesional SMA, and contralesional ROIs and mIn levels in all ROIs have nonsignificant predictive value (P values varied between 0.05 and 1.0) ( Table 3 ). When each of traditional predictors has been examined, all had relatively low and nonsignificant predictive value of therapy-related clinical or kinematic change (P varied between 0.05 and 1.0, Table 3 ).
H-MRS Biomarkers Were not Significantly Correlated With Traditional Predictors
Importantly, none of the 1 H-MRS biomarkers had significant relationships with the traditional predictors (Table 4) .
DISCUSSION
To our knowledge, this is the first demonstration that pre-therapy 1 H-MRS biomarkers of neural state of the motor and premotor cortices might be worthwhile for predicting therapy-related motor gain in chronic subcortical stroke. Although in a very small sample (n = 10), the results confirm prior neuroimaging/neurophysiological findings, 7, 8 demonstrating the role of these areas in predicting therapy gain after stroke. Specifically, this study revealed four main results. First, consistent with our predictions, the pre-therapy biomarkers of intracortical excitability (Glx) in the ipsilesional M1 and PM and of neuronal metabolic integrity (NAA) in the ipsilesional PM were associated positively with the magnitude of motor gain. Second, as predicted, the biomarkers of intracortical excitability in the contralesional M1 were negatively associated with motor gain. Third, contrary to our predictions, the biomarkers of intracortical excitability in the contralesional SMA were positively related to motor gain. Importantly, no such relationships were detected in other candidate predictors (glial biomarkers) assessed in all areas, indicating that these effects are quite selective in nature. Fourth, the 1 H-MRS biomarkers reported previously outperformed the traditional predictors of stroke recovery. Below, we discuss each of these finding as well as their potential implications in greater detail.
Depressed Excitability in Ipsilesional M1 and PM Was Associated With Poor Motor Gain
As predicted, the pre-therapy levels of Glx (glutamateglutamine) in the ipsilesional M1 and PM were significantly correlated with therapy-related gain (Table 3, Fig. 3A) . Specifically, participants with lower cortical Glx levels had poorer change in clinical scores/kinematics metrics. Lower Glx levels are thought to be indicative of decreased intracortical excitability. 26 This finding is in line with the overwhelming evidence from human studies (see review by Stinear et al. 27 ) demonstrating increased tonic neuronal inhibition ipsilesionally after stroke. For instance, excessive inhibitory drive exercised by contralesional motor areas on the ipsilesional homotopic areas could be responsible for such reduction in ipsilesional excitability. 28 In line with the results of the current study, a series of transcranial magnetic stimulation studies have demonstrated that the increase of the excitability of the ipsilesional M1, directly or by reducing excessive interhemispheric inhibition from the contralesional hemisphere, facilitates motor recovery. 24 This is also consistent with evidence showing that an increase in excitability is required for use-dependent plasticity or motor learning in these patients. 29 In summary, the lower levels of Glx in these areas are likely to be reflective of decreased (suppressed) ipsilesional intracortical excitatory activity, which, in turn, induces a less suitable environment for use-dependent neural plasticity.
Depression of the Neuronal Metabolism in Ipsilesional PM Was Associated With Poor Motor Gain
Consistent with our predictions, the level of NAA in the ipsilesional PM had a predictive value (Table 3, Fig. 3A) . However, contrary to our predictions, the predictive value of the level of NAA in the ipsilesional M1 did not reach statistical significance. A possible explanation for this is the small sample size; perhaps a larger sample would reach statistical significance. An alternative explanation could be the enrollment of patients with motor deficits spanning a relatively wide range (70% of participants were moderately to severely impaired and 30% had mild impairment). Specifically, in those with more severe impairment, the M1 output is likely to be damaged, whereas the PM output is expected to have a higher probability to survive, making this area (and its corticospinal/ reticulospinal pathways) an alternative cortical substrate in face of the injury to the original output (see review by Plow et al. 25 ).
The current results of the positive relationship between the levels of NAA in the ipsilesional PM and the therapy gain confirm the potential role of this area in recovery of movement. Specifically, lower levels of NAA might reflect neuronal metabolic dysfunction.
11 This is in line with previous reports demonstrating morphological and metabolic cell body changes after axonal injury (in our case, at the subcortical level) and/ or metabolic abnormalities associated with diaschisis. 30 Indeed, dysfunctional neurons seem to be associated with less synthesis of brain-derived neurotrophic factor and neurotransmission related-proteins, which, in turn, might impact usedependent plasticity. 31 Thus, it seems that patients with more dysfunctional neurons in the ipsilesional PM would have low reserve to improve behavioral outcome in response to therapy, by having less potential to increase the drive to spared corticospinal or other pathways (see previous details) to boost the output projecting to the paretic upper limb.
Depressed Excitability in Contralesional M1 Was Associated With Greater Motor Gain
As hypothesized, the levels of Glx in contralesional M1 were negatively related to the therapy gain (Table 3 , Fig. 3B ). Although the ipsilesional M1 is undoubtedly critical for recovery, the role of the contralesional M1 is still inconclusive (see review by Buetefisch 28 ). Being spared by ischemic events and based on its role in high-level motor control and possible role in the control of the ipsilateral hand movements, this area could be particularly well suited to contribute to upper limb performance after stroke. 28 Evidence from human studies 28 demonstrating structural and functional reorganization within contralesional M1 has made this argument even more compelling. Indeed, an abnormally increased excitatory neural activity and activation have been reported in contralesional M1 after stroke. Some investigations contend that these changes have maladaptive relevance. 13 Our finding supports this hypothesis. Specifically, lower intracortical excitability in this area is likely to be associated with greater decrease in behavioral compensation that, in turn, could be interpreted as greater motor recovery. Notably, the contralesional M1 biomarkers did not show significant correlations with clinical gain. This is not surprising because, as stated previously, clinical testing is often not qualitatively sensitive enough to discriminate between true recovery (adaptive) and compensation (maladaptive strategy at the behavioral level). 22 Thus, the trunk metrics reported here allowed us not only to understand the movement strategy employed by patient to improve its function but also to differentiate between adaptive versus maladaptive plasticity at the neural level (i.e., contralesional M1).
Depressed Excitability in Contralesional SMA Was Associated With Poor Motor Gain
Contrary to our expectations, the level of Glx in the contralesional SMA was positively correlated with clinical gain (Table 3 , Fig. 3B ), suggesting an adaptive role in mediating motor recovery, at least as 1 H-MRS metrics could discern. These findings broadly emphasize that the reorganizational changes in contralesional hemisphere are quite selective in nature for the brain regions engaged in stroke recovery. Furthermore, the effects of the time post-stroke on the role of this area in stroke recovery corroborates well with prior animal studies showing a temporal disparity between neurophysiological/ neuroanatomical changes in SMA and behavioral changes during spontaneous recovery. 32 Precisely, this result further supports the possible critical engagement of this area in recovery processes during the late phases of stroke. Knowing how and when a specific cortical resource (i.e., M1, PM, SMA) contributes to recovery after stroke is crucial to tailor new interventions (i.e., non-invasive brain stimulation), and more studies are needed to clarify this.
Taken together, these findings suggest that training-induced motor gain is related to the level of excitatory activity measured pre-therapy in two ipsilesional and two contralesional cortical areas and to the neuronal integrity in one ipsilesional area. As stated previously, these areas may serve as potential anatomic substrate for this process. We, therefore, speculate that 1 H-MRS biomarkers could be indicators of brain tissue state that reflects the cerebral resource. Indeed, without a sufficient cerebral resource, the therapy may not help. We may speculate that there might be a critical molecular/cellular level of the cerebral reserve related to the ability of the patient to respond to a motor therapy. This critical level might be defined by a bimodal distribution of the excitability state in both ipsilesional and contralesional motor/premotor cortices and neuronal state of ipsilesional PM, but studies in larger populations are necessary for the development of this concept. The notion of a critical level being related to response to a therapy may have prognostic value: patients falling below this level (less excitable/more dysfunctional neurons) may be nonresponders, whereas patients above this level may retain the ability to respond to a therapy. Therefore, such biomarker could serve for patient's selection in stroke recovery/ rehabilitation trials. Furthermore, identification of the remaining cerebral resources that could support the paretic upper limb function may become essential in development of targeted, individualized therapies, i.e., non-invasive brain stimulation. As the restorative therapies proceed after stroke, such biomarkers could be also used to reveal the progress of therapy and to guide quantitative therapy choices: pushing the potential for gains by continuing a therapy until no further neurochemical changes in regions of interest occur, ensuring that the reorganizational potential of these regions has peaked, at least as 1 H-MRS can discern. However, we recommend caution in interpreting these results until more work is completed. If evidence continues to mount that 1 H-MRS metrics add value to stroke prediction, support will be also needed to ensure MR spectroscopy is accessible in a standardized fashion across hospitals.
It is important to note that the predictive value of 1 H-MRS biomarkers was selective to Glx and NAA and not evident for mIn (Table 3) . This is consistent with the hypothesis that after years and even decades after injury, there is a low probability to find gliosis/demyelination or inflammation processes in these territories. 33 Alternatively, it may be that glial marker (in isolation) is not sensitive enough to provide information about the remaining cerebral resources needed for the therapy to help. (Table 3 ). The current results regarding the age of patient, time post-stroke, and infarct volume are largely consistent with previous studies (see review by Coupar et al. 5 ) reporting inconclusive evidence of association between these variables and motor recovery. Our current results regarding the pre-therapy clinical impairment (as measured by FM total) are in contrast with a recent meta-analysis, reporting the important value of baseline clinical assessments for response to restorative therapies. 5 This could be explained by the low predictive value of the baseline clinical impairment in those with more severe hemiparesis. 34 Specifically, in a population with a baseline clinical severity (FM = 32.5 [25.3] points) similar to our sample (FM = 35.6 [18.6] points), the clinical impairment at 24-to 72-hr post-infarct was a strong predictor of recovery at 3-to 6-mo post-infarct when those with severe impairment were removed. 34 Overall, our results confirm prior studies 5, 8 showing that traditional predictors alone have minimal to moderate association with behavioral gains from restorative therapies in chronic patients. We, therefore, advocate that the measures of the microscopic cellular level of spared motor/ premotor cortices-a level that is not detected by the currently in use imaging or clinical approaches-may improve prediction models by providing information about the remaining cerebral resources required to boost activity associated with recovering upper limb movement in response to a restorative therapy.
Limitations and Strengths
This study is limited by small sample size. However, one strength of this study was the use of restrictive inclusion criteria and a controlled motor learning paradigm to reduce heterogeneity, so the current findings are relevant to this particular stroke type and location, as well as for this type of training. All patients were able to communicate and understand simple commands, limiting the generalizability to those with severe receptive aphasia or cognitive impairment. Given that the patients were in the chronic stage of stroke, the current results might not be applicable to acute or subacute stages. The meaningful clinical improvement (which would be >four points on the FM scale) associated with the motor training paradigm used in the current study was not discussed here, because the study was not designed to evaluate the overall behavioral effects of this training. We did not record whether the study participants have gone through similar therapeutic interventions before starting participation in this study. Thus, we cannot rule out that their capacity for improvement has been already achieved before participation. However, it is not surprisingly that some patients improved more than others-not all stroke survivors retain the capacity to respond to therapy. During the kinematic assessment, the forearm rotation may contribute to elbow extension calculation. This possible elbow extension error has not been evaluated here. The pre-stroke hand dominance has been reported to impact motor recovery 35 and should be also taken into account in future studies. As stated previously, a multimodal approach, i.e., including metrics of neural injury and cerebral resources, is likely to be the best approach to predict behavioral gains from a restorative therapies in chronic stroke. 7, 8 Unfortunately, the sample size in the current study was insufficient to investigate such combinations.
CONCLUSIONS
The preliminary data of the current study suggest that 1 H-MRS measures of structurally intact motor and premotor areas in both ipsilesional and contralesional hemispheres might be useful to predict behavioral gains from a restorative therapy in chronic stroke. Further study to confirm whether these findings may be generalized to the stroke survivor population as a whole in a larger sample is warranted. Although kinematic analysis is time-consuming, we also advocate that when a therapy seems to enhance recovery, the use of a combined movement kinematics-neuroimaging approach may facilitate distinctions between recovery and compensation at both neural and behavioral levels.
